Veronika-Viktorija Borutinskaitė

The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines

Jūratė Savickienė, Veronika-Viktorija Borutinskaitė, Gražina Treigytė et al. · European Journal of Pharmacology · 2006 · 44 citations

Histone Modifications, Chromatin, Hematological Malignancy +11

DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E‐cadherin re‐expression by chromatin remodelling

Jūratė Savickienė, Gražina Treigytė, Arune Jazdauskaite et al. · Cell Biology International · 2012 · 32 citations

Histone Modifications, Epigenetic Change, Dna Methylation +27

Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells

Jūratė Savickienė, Gražina Treigytė, Veronika-Viktorija Borutinskaitė et al. · Cellular & Molecular Biology Letters · 2012 · 30 citations · Full text

Diverse Dnmt Inhibitors, Mixed-phenotype Acute Leukemia, Pharmacotherapy +16

Epigenetic changes by zebularine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells

Jūratė Savickienė, Gražina Treigytė, Violeta Jonušienė et al. · Molecular and Cellular Biochemistry · 2011 · 25 citations

Hematological Malignancy, Chromatin, Developmental Biology +9

Alpha-Dystrobrevin and its associated proteins in human promyelocytic leukemia cells induced to apoptosis

Rūta Navakauskienė, Gražina Treigytė, Veronika-Viktorija Borutinskaitė et al. · Journal of Proteomics · 2012 · 13 citations

Medicine, Apoptosis, Associated Proteins +7